Skip to main content
Premium Trial:

Request an Annual Quote

H9, H7 et al. Approved for Federally Funded Research

The Washington Post reports that the National Institutes of Health has approved 13 additional human embryonic stem cell lines as eligible for federal funding this week. On the list is H9 — the most widely used hESC line, developed by researchers at the University of Wisconsin, Madison-affiliated WiCell Research Institute, which had previously been approved under the administration of former President Bush. "Many people who had been working on these lines, and concerned about whether they would be able to continue to work with these lines, will now be reassured that their research can now go forward," NIH Director Francis Collins said Tuesday, according to the Post article.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.